Comparative analysis revealed PEP20-containing MP@CH/BSA (L +) significantly outperformed M@CH/BSA controls in macrophage recruitment (Fig. 16f) and tumor suppression metrics, achieving maximal inhibition of primary tumor growth and pulmonary metastasis. The gene discussed is C4B; the disease is neoplasm.